Mitoxantrone Hydrochloride Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Also known as: CL 232315, DHAD, DHAQ, Dihydroxyanthracenedione Dihydrochloride, Mitoxantrone Dihydrochloride +7 more

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

St. Jude Children's Research Hospital1
Children's Oncology Group1

Indications

Acute Myeloid Leukemia2
Cancer2

Birmingham, Alabama1 trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Children's Hospital of Alabama

Phase 3

Madera, California1 trial

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Valley Children's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.